{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:29:21Z","timestamp":1790666961069,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Gastrointestinal (GI) cancers such as colorectal cancer (CRC), gastric cancer (GC), esophageal cancer (EG), pancreatic duct adenocarcinoma (PDAC) or hepatocellular cancer (HCC) belong to the most commonly diagnosed types of cancer and are among the most frequent causes of cancer related death worldwide. Most types of GI cancer develop in a stepwise fashion with the occurrence of various driver mutations during tumor progression. Understanding the precise function of mutations driving GI cancer development has been regarded as a prerequisite for an improved clinical management of GI malignancies. During recent years, CRISPR\/Cas9 has developed into a powerful tool for genome editing in cancer research by knocking in and knocking out even multiple genes at the same time. Within this review, we discuss recent applications for CRISPR\/Cas9-based genome editing in GI cancer research including CRC, GC, EG, PDAC and HCC. These applications include functional studies of candidate genes in cancer cell lines or organoids <jats:italic>in vitro<\/jats:italic> as well as in murine cancer models <jats:italic>in vivo<\/jats:italic>, library screening for the identification of previously unknown driver mutations and even gene therapy of GI cancers.<\/jats:p>","DOI":"10.3389\/fcell.2021.727217","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:54:42Z","timestamp":1638366882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["CRISPR\/Cas9 in Gastrointestinal Malignancies"],"prefix":"10.3389","volume":"9","author":[{"given":"Andr\u00e9","family":"Jefremow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian J.","family":"Waldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00432-018-2625-5","article-title":"High MLL2 Expression Predicts Poor Prognosis and Promotes Tumor Progression by Inducing EMT in Esophageal Squamous Cell Carcinoma","volume":"144","author":"Abudureheman","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/hep.30190","article-title":"Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy","volume":"69","author":"Ardelt","year":"2019","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1053\/j.gastro.2020.05.052","article-title":"Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles from Cancer Cells that Promote Metastasis to Lung in Mice","volume":"159","author":"Armacki","year":"2020","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"108676","DOI":"10.1016\/j.celrep.2020.108676","article-title":"Genome-Wide CRISPR-Cas9 Knockout Library Screening Identified PTPMT1 in Cardiolipin Synthesis Is Crucial to Survival in Hypoxia in Liver Cancer","volume":"34","author":"Bao","year":"2021","journal-title":"Cel. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR Technologies in Research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR Provides Acquired Resistance against Viruses in Prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered Regularly Interspaced Short Palindrome Repeats (CRISPRs) Have Spacers of Extrachromosomal Origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology (Reading)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer J. Clinicians"},{"key":"B9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.31094","article-title":"Modulation of Biliary Cancer Chemo\u2010Resistance through MicroRNA\u2010Mediated Rewiring of the Expansion of CD133+ Cells","volume":"72","author":"Carotenuto","year":"2020","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41389-019-0145-z","article-title":"A Functional CRISPR\/Cas9 Screen Identifies Kinases that Modulate FGFR Inhibitor Response in Gastric Cancer","volume":"8","author":"Chen","year":"2019","journal-title":"Oncogenesis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41389-019-0171-x","article-title":"The Protein Kinase CK2 Contributes to the Malignant Phenotype of Cholangiocarcinoma Cells","volume":"8","author":"Di Maira","year":"2019","journal-title":"Oncogenesis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1158\/1535-7163.MCT-19-0822","article-title":"An RNA-Binding Protein, Hu-Antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells","volume":"19","author":"Dong","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"The New Frontier of Genome Engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature14415","article-title":"Sequential Cancer Mutations in Cultured Human Intestinal Stem Cells","volume":"521","author":"Drost","year":"2015","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1053\/j.gastro.2017.09.008","article-title":"CRISPR\/Cas9 Engineering of Adult Mouse Liver Demonstrates that the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma","volume":"153","author":"Engelholm","year":"2017","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/cancers11121904","article-title":"Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer","volume":"11","author":"Erlangga","year":"2019","journal-title":"Cancers"},{"key":"B17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-i","article-title":"A Genetic Model for Colorectal Tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3978\/j.issn.2078-6891.2012.030","article-title":"Colorectal Carcinoma: Pathologic Aspects","volume":"3","author":"Fleming","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2018.11.048","article-title":"Modeling Human Digestive Diseases with CRISPR-Cas9-Modified Organoids","volume":"156","author":"Fujii","year":"2019","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-016-0478-9","article-title":"FGF19\/FGFR4 Signaling Contributes to the Resistance of Hepatocellular Carcinoma to Sorafenib","volume":"36","author":"Gao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.pmbts.2016.09.008","article-title":"Molecular Pathogenesis of Pancreatic Cancer","volume":"144","author":"Grant","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3389\/fphar.2018.01118","article-title":"Disruption of PD-1 Enhanced the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/cancers12051105","article-title":"TESC Promotes TGF-\u0391\/egfr-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma","volume":"12","author":"Hsieh","year":"2020","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide Sequence of the Iap Gene, Responsible for Alkaline Phosphatase Isozyme Conversion in Escherichia Coli, and Identification of the Gene Product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hep.28411","article-title":"Aspartate \u03b2-Hydroxylase Modulates Cellular Senescence through Glycogen Synthase Kinase 3\u03b2 in Hepatocellular Carcinoma","volume":"63","author":"Iwagami","year":"2016","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2020.5.11","article-title":"Beyond the Border: The Use of Lenvatinib in Advanced Hepatocellular Carcinoma after Different Treatment Lines: a Retrospective Analysis","volume":"71","author":"Jefremow","year":"2020","journal-title":"J. Physiol. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.18632\/oncotarget.7420","article-title":"DEPTOR Suppresses the Progression of Esophageal Squamous Cell Carcinoma and Predicts Poor Prognosis","volume":"7","author":"Ji","year":"2016","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5625\/lar.2018.34.4.257","article-title":"Disruption of the Tff1 Gene in Mice Using CRISPR\/Cas9 Promotes Body Weight Reduction and Gastric Tumorigenesis","volume":"34","author":"Kim","year":"2018","journal-title":"Lab. Anim. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus Sorafenib in First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Randomised Phase 3 Non-inferiority Trial","volume":"391","author":"Kudo","year":"2018","journal-title":"The Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular Targeted Therapies: Ready for \"Prime Time\" in Biliary Tract Cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41388-020-01523-5","article-title":"Genome-Wide CRISPR Screen Identifies LGALS2 as an Oxidative Stress-Responsive Gene with an Inhibitory Function on colon Tumor Growth","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/OTT.S225556","article-title":"Cas9 Mediated Correction of \u03b2-Catenin Mutation and Restoring the Expression of Protein Phosphorylation in Colon Cancer HCT-116 Cells Decrease Cell Proliferation In Vitro and Hamper Tumor Growth in Mice In Vivo","volume":"13","author":"Li","year":"2020","journal-title":"Onco Targets Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9899","DOI":"10.2147\/OTT.S226851","article-title":"PDHA1 Gene Knockout in Human Esophageal Squamous Cancer Cells Resulted in Greater Warburg Effect And Aggressive Features In Vitro And In Vivo","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in Advanced Hepatocellular Carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","article-title":"A CRISPR\/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation","volume":"11","author":"Lo","year":"2021","journal-title":"Cancer Discov."},{"key":"B39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nm.3802","article-title":"Modeling Colorectal Cancer Using CRISPR-Cas9-Mediated Engineering of Human Intestinal Organoids","volume":"21","author":"Matano","year":"2015","journal-title":"Nat. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.stem.2020.04.003","article-title":"Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids","volume":"26","author":"Michels","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2018.01.002","article-title":"Hallmarks of Cancer: The CRISPR Generation","volume":"93","author":"Moses","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","article-title":"Divergent Routes Toward Wnt and R-Spondin Niche Independency during Human Gastric Carcinogenesis","volume":"174","author":"Nanki","year":"2018","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4251\/wjgo.v6.i5.112","article-title":"Esophageal Cancer: A Review of Epidemiology, Pathogenesis, Staging Workup and Treatment Modalities","volume":"6","author":"Napier","year":"2014","journal-title":"World J. Gastrointest. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.18632\/oncotarget.14447","article-title":"Eukaryotic Elongation Factor 2 Is a Prognostic Marker and its Kinase a Potential Therapeutic Target in HCC","volume":"8","author":"Pott","year":"2017","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR Elements in Yersinia Pestis Acquire New Repeats by Preferential Uptake of Bacteriophage DNA, and Provide Additional Tools for Evolutionary Studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology (Reading)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stem.2020.02.007","article-title":"Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-\u03b2 Resistance","volume":"26","author":"Ringel","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.3836","article-title":"In Vivo genome Editing and Organoid Transplantation Models of Colorectal Cancer and Metastasis","volume":"35","author":"Roper","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1158\/2159-8290.CD-15-1442","article-title":"Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma","volume":"6","author":"Saha","year":"2016","journal-title":"Cancer Discov."},{"key":"B50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc3950","article-title":"Applications of the CRISPR-Cas9 System in Cancer Biology","volume":"15","author":"S\u00e1nchez-Rivera","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A. Cancer J. Clin."},{"key":"B53","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41374-018-0027-6","article-title":"Genome-Wide CRISPR Screen Reveals SGOL1 as a Druggable Target of Sorafenib-Treated Hepatocellular Carcinoma","volume":"98","author":"Sun","year":"2018","journal-title":"Lab. Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1053\/j.gastro.2015.05.059","article-title":"Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma","volume":"149","author":"Tan","year":"2015","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/nejm198809013190901","article-title":"Genetic Alterations during Colorectal-Tumor Development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer Genome Landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/anie.201708689","article-title":"Thermo-Triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy","volume":"57","author":"Wang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"B58","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-Wide CRISPR\/Cas9 Library Screening Identified PHGDH as a Critical Driver for Sorafenib Resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat. Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-019-13420-x","article-title":"Genome-Wide CRISPR Screen Identifies ELP5 as a Determinant of Gemcitabine Sensitivity in Gallbladder Cancer","volume":"10","author":"Xu","year":"2019","journal-title":"Nat. Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1136\/gutjnl-2016-311849","article-title":"RNF43 Germline and Somatic Mutation in Serrated Neoplasia Pathway and its Association with BRAF Mutation","volume":"66","author":"Yan","year":"2017","journal-title":"Gut"},{"key":"B61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fcell.2019.00239","article-title":"CRISPR Cas9 in Pancreatic Cancer Research","volume":"7","author":"Yang","year":"2019","journal-title":"Front. Cel. Dev. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"649896","DOI":"10.3389\/fmed.2021.649896","article-title":"CRISPR\/Cas: Advances, Limitations, and Applications for Precision Cancer Research","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1158\/0008-5472.CAN-17-2043","article-title":"Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers","volume":"77","author":"Yau","year":"2017","journal-title":"Cancer Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"29220","DOI":"10.18632\/oncotarget.25678","article-title":"Development of an Integrated CRISPRi Targeting \u0394Np63 for Treatment of Squamous Cell Carcinoma","volume":"9","author":"Yoshida","year":"2018","journal-title":"Oncotarget"},{"key":"B65","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/carcin\/bgz179","article-title":"Loss of ARID1A Induces a Stemness Gene ALDH1A1 Expression with Histone Acetylation in the Malignant Subtype of Cholangiocarcinoma","volume":"41","author":"Yoshino","year":"2020","journal-title":"Carcinogenesis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtm.2019.02.008","article-title":"Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research","volume":"13","author":"You","year":"2019","journal-title":"Mol. Ther. - Methods Clin. Develop."},{"key":"B67","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neo.2016.12.007","article-title":"PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail","volume":"19","author":"Zhai","year":"2017","journal-title":"Neoplasia"},{"key":"B68","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.semcancer.2018.04.001","article-title":"CRISPR\/Cas9 for Cancer Research and Therapy","volume":"55","author":"Zhan","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.gastro.2018.09.046","article-title":"Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells","volume":"156","author":"Zhang","year":"","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.biopha.2018.12.048","article-title":"CRISPR\/Cas9-Mediated Knockout of the PDEF Gene Inhibits Migration and Invasion of Human Gastric Cancer AGS Cells","volume":"111","author":"Zhang","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B71","first-page":"1183","article-title":"Genome-Scale CRISPR Activation Screening Identifies a Role of ELAVL2-Cdkn1a Axis in Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma","volume":"9","author":"Zhao","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic Landscape and Biomarkers of Hepatocellular Carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.727217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:54:48Z","timestamp":1638366888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.727217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":72,"alternative-id":["10.3389\/fcell.2021.727217"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.727217","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"727217"}}